Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01855412 · ClinicalTrials.gov registry record
Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 1,204
- Enrollment target
NCT01855412: Completed study, sponsored by Abbott Medical Devices.
NCT01855412 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 1,204 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01855412 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 1,204 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).
Primary Outcome
Final post-procedural result of \<50% residual stenosis for all treated lesions for a participant during index procedure and without angiographic complications as determined by the Angiographic Core Laboratory.
Interventions
- OTHER PAD endovascular treatments
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,204 participants |
| Start Date | 2013-05 |
| Est. Completion | 2019-04-11 |
What the finished NCT01855412 record still lists
NCT01855412 is an observational study that tracks outcomes without assigning an intervention. Its 1,204 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which PAD endovascular treatments is the first listed.
NCT01855412 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01855412 about?
NCT01855412 is a clinical study titled "Observational Study to Evaluate PAD Treatment Clinical and Economic Outcomes". The purpose of this study is to evaluate acute and long term clinical and economic outcomes of endovascular procedures to treat Peripheral Arterial Disease (PAD).
What is the current status of trial NCT01855412?
This trial is currently completed. The enrollment target is 1,204 participants. The study started on 2013-05. Estimated completion is 2019-04-11.
What interventions are being tested in trial NCT01855412?
The interventions under investigation include: PAD endovascular treatments (OTHER).
Who is sponsoring clinical trial NCT01855412?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07038785 · 1,204 participants
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
- NCT06535854 · 1,205 participants · NA
Prevail Global Study
- NCT07223593 · 1,205 participants · Phase 3
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
- NCT00001987 · 1,200 participants
Genetic Studies of Insulin and Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia